Cargando…
Management of predictable pain using fentanyl pectin nasal spray in patients undergoing radiotherapy
BACKGROUND: Studies report the need for improved pain management in the radiation oncology setting. Many patients with well controlled background pain experience breakthrough pain in cancer (BTPc) that can interrupt their treatment schedule with a potentially negative impact on outcomes. BTPc can be...
Autores principales: | Bell, Brent C, Butler, E Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864880/ https://www.ncbi.nlm.nih.gov/pubmed/24376361 http://dx.doi.org/10.2147/JPR.S54788 |
Ejemplares similares
-
Patient Satisfaction with Fentanyl Pectin Nasal Spray in Breakthrough Cancer Pain Management During Radiotherapy for Head and Neck Cancer
por: Pointreau, Yoann, et al.
Publicado: (2020) -
Efficacy, safety, and tolerability of fentanyl pectin nasal spray in patients with breakthrough cancer pain
por: Ueberall, Michael A, et al.
Publicado: (2016) -
Use of Fentanyl Iontophoretic Transdermal System (ITS) (IONSYS(®)) in the Management of Patients with Acute Postoperative Pain: A Case Series
por: Poplawski, Steven, et al.
Publicado: (2016) -
Fentanyl Sublingual Spray for Breakthrough Pain in Cancer Patients
por: Zeppetella, Giovambattista
Publicado: (2013) -
Comparison of analgesia, adverse effects, and quality of life in cancer patients during treatment of procedural pain with intravenous morphine, fentanyl nasal spray, and fentanyl buccal tablets
por: Piotrowska, Wieslawa, et al.
Publicado: (2019)